openPR Logo
Press release

RELEASE: NEW HAIR-BASED CANCER TEST OFFERS HOPE FOR HEALTHEQUITY IN DIAGNOSIS

09-16-2025 08:05 AM CET | Health & Medicine

Press release from: Strands For Caner

Your hair holds the key to saving lives through early cancer detection.

Your hair holds the key to saving lives through early cancer detection.

BALTIMORE, MD - A team of researchers led by renowned researcher and oncologist Dr. Kenneth
Pienta, has made a potentially revolutionary discovery in cancer diagnosis. In collaboration with
Dr. Emma Hammarlund, Dr. Kazi Uddin, and Dr. Per Malmberg, Dr. Pienta's team has preliminarily
demonstrated that it may be possible to detect cancer through the analysis of a person's hair. This
groundbreaking research offers the promise of a non-invasive, inexpensive, and highly accurate
diagnostic tool that could transform early cancer detection. The standard diagnostic procedure for many types of cancer, such as a positron emission tomography (PET) scan, is often expensive, time-consuming, and can have a significant margin of error. Early diagnosis is critical to successful treatment, yet the tools and procedures readily available today can make it challenging to detect cancer before it spreads. This novel research addresses these challenges head-on. "Cancer is an incredibly metabolically active disease," explains Dr. Pienta. "Our team has discovered a method to detect the subtle, yet significant, metabolic changes that a growing cancer causes. We believe that a person's hair provides a reflection of the hidden cancer, offering a unique and non-invasive way to see what's happening inside the body. "The research team is currently in the process of a large-scale study, collecting hair samples from individuals with and without cancer to further analyze the samples and definitively prove the efficacy of this new diagnostic test. If successful, this research could lead to a new era of cancer screening, allowing for earlier intervention, greater access to testing and improved patient outcomes. We are formally requesting an interview with Dr. Kenneth Pienta to discuss this groundbreaking research in detail. An interview would provide a valuable opportunity for the public and the medical community to learn about the potential of this innovative diagnostic tool and the next steps for the research team. For interviews contact: Amber Myers 614-314-7999. Strands@strandsforcancer.com

Element Biosciences
1812 Ashland Ave, Suite 100, Baltimore, MD 21205
(410)929-3465
strands@strandsforcancer.com
Kenneth Pienta, MD
Cancer biologist and medical oncologist
www.strandsforcancer.com

Dr. Ken Pienta, in partnership with Dr. Emma Hammarlund, Dr. Kazi Uddin, and Dr. Per Malmberg may have preliminarily demonstrated that it may be possible to detect cancer using a person's hair.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release RELEASE: NEW HAIR-BASED CANCER TEST OFFERS HOPE FOR HEALTHEQUITY IN DIAGNOSIS here

News-ID: 4183440 • Views:

More Releases for Pienta

Ferumoxtran, the iron-based investigational MRI contrast agent of SPL Medical B. …
Nijmegen, The Netherlands, 26.05.2025 - SPL Medical B.V. announced today further results of the pivotal phase III study PROSTAPROGRESS (EudraCT 2018-004310-18), aiming to assess the diagnostic accuracy of Ferumoxtran enhanced Magnetic Resonance Imaging (MRI) for lymph node detection in prostate cancer patients. Patients with known prostate cancer with intermediate to high risk of lymph node metastases without prior treatment were enrolled in the trial. The multicentric prospective PROSTAPROGRESS study has not